Clinical trial · Observational
Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features
NCT06604377CI-TRIAL-00080573completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to investigate the predictive value of preoperative 18F-PSMA-1007 PET/MR in the predictive effect of biological recurrence (BCR) after radical prostatectomy (RP) for localized prostate cancer (PCa).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observe | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Shanghai East Hospital, Tongji University School of Medicine
- description
- Patients diagnosed with prostate cancer undergoing PSMA PET/MR examination prior to surgery.
- interventionNames
- Other: Observe
Primary outcomes (1)
- measure
- 18F-PSMA-1007 PET/MR image parameters
- timeFrame
- Before surgery
Secondary outcomes (1)
- measure
- Biochemical recurrence-free survival time
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age ≥ 18 years 2. Histologically confirmed prostate cancer without other types of malignancy - Exclusion Criteria: 1.Surgery or endocrine therapy is performed prior to the examination \-
References
Publications (1)
pubmedProvenance
- Source
- PubMed (NLM)
- Dataset
- PubMed E-utilities
- Retrieved
- Sep 16, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
Jiajia Hu, Hangxing Chunyu, Yihong Yang et al. · Eur J Nucl Med Mol Imaging · Sep 15, 2026 · PMID 42736457 pubmed